Hepatitis B Virus
GILEAD LAUNCHES GLOBAL ALL4LIVER GRANT PROGRAM TO HELP ACHIEVE THE WORLD HEALTH ORGANIZATION’S GOAL OF VIRAL HEPATITIS ELIMINATION BY 2030
2023-07-28
Vir Biotech’s Investigational Antibody Therapy Shows Promise in 8-Patient Phase 1 HBV Trial
2021-01-27
Envafolimab, the First Subcutaneously Administered PD-L1 Antibody for HBV Enters Phase IIb Study
2020-12-07
LATEST
Crossing Borders for a New Era in Medical Service Standards: Highlights from the 1st Asia Pacific Forum on Healthcare Quality
2024-12-12
Precision Medicine in Breast & Lung Cancer: Coordinated Diagnostics and Treatment Approaches for Personalized Care
2024-12-12
Fighting the Good Fight: Global Experts Unite to Share Oncology Breakthroughs at Asia-Pacific Precision Cancer Treatment Forum
2024-12-12